Such a scenario might be of therapeutic relevance, as complete ablation of SETD2 may preferentially impact leukemia cells harboring heterozygous mutations of SETD2. However, homozygous depletion of SETD2 in T-cells was associated with rapid expansion of the γδ-T-cell population [21]. The gene discussed is SETD2; the disease is leukemia.